Cargando…

Senescence plays a role in myotonic dystrophy type 1

Myotonic dystrophy type 1 (DM1; MIM #160900) is an autosomal dominant disorder, clinically characterized by progressive muscular weakness and multisystem degeneration. The broad phenotypes observed in patients with DM1 resemble the appearance of an accelerated aging process. However, the molecular m...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Puga, Mikel, Saenz-Antoñanzas, Ander, Gerenu, Gorka, Arrieta-Legorburu, Alex, Fernández-Torrón, Roberto, Zulaica, Miren, Saenz, Amets, Elizazu, Joseba, Nogales-Gadea, Gisela, Gadalla, Shahinaz M., Araúzo-Bravo, Marcos J., López de Munain, Adolfo, Matheu, Ander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675450/ https://www.ncbi.nlm.nih.gov/pubmed/36040809 http://dx.doi.org/10.1172/jci.insight.159357

Ejemplares similares

Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin
por: García-Puga, Mikel, et al.
Publicado: (2020)

Targeting Myotonic Dystrophy Type 1 with Metformin
por: García-Puga, Mikel, et al.
Publicado: (2022)

Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study
por: Wang, Youjin, et al.
Publicado: (2019)

Muscle wasting in myotonic dystrophies: a model of premature aging
por: Mateos-Aierdi, Alba Judith, et al.
Publicado: (2015)

SOX9 promotes tumor progression through the axis BMI1-p21(CIP)
por: Aldaz, Paula, et al.
Publicado: (2020)

CRISPR/Cas9 Deletion of SOX2 Regulatory Region 2 (SRR2) Decreases SOX2 Malignant Activity in Glioblastoma
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2021)

Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?
por: Labayru, Garazi, et al.
Publicado: (2018)

Age‐related cognitive decline in myotonic dystrophy type 1: An 11‐year longitudinal follow‐up study
por: Labayru, Garazi, et al.
Publicado: (2019)

Relevance of oxidative stress and inflammation in frailty based on human studies and mouse models
por: Álvarez-Satta, María, et al.
Publicado: (2020)

CD8(+) T cells are increased in the subventricular zone with physiological and pathological aging
por: Moreno‐Valladares, Manuel, et al.
Publicado: (2020)

CD8(+) T cells are present at low levels in the white matter with physiological and pathological aging
por: Moreno-Valladares, Manuel, et al.
Publicado: (2020)

Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity
por: Auzmendi-Iriarte, Jaione, et al.
Publicado: (2022)

Autophagy in stem cell aging
por: Revuelta, Miren, et al.
Publicado: (2017)

Shedding light on motor premanifest myotonic dystrophy type 1: A molecular, muscular and central nervous system follow‐up study
por: Garmendia, Joana, et al.
Publicado: (2022)

Towards precision medicine: linking genetic and cellular heterogeneity in gastric cancer
por: Carrasco-Garcia, Estefania, et al.
Publicado: (2018)

Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2019)

Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma
por: Auzmendi-Iriarte, Jaione, et al.
Publicado: (2020)

Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1
por: Labayru, Garazi, et al.
Publicado: (2019)

The Biomarker Potential of miRNAs in Myotonic Dystrophy Type I
por: Koehorst, Emma, et al.
Publicado: (2020)

PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
por: Torres-Bayona, Sergio, et al.
Publicado: (2018)

Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors
por: Torres-Bayona, Sergio, et al.
Publicado: (2022)

Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers
por: Fernandez-Costa, Juan M., et al.
Publicado: (2016)

An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I
por: López-Martínez, Andrea, et al.
Publicado: (2020)

T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians
por: Alberro, Ainhoa, et al.
Publicado: (2019)

Inflammaging markers characteristic of advanced age show similar levels with frailty and dependency
por: Alberro, Ainhoa, et al.
Publicado: (2021)

Inflammaging and Frailty Status Do Not Result in an Increased Extracellular Vesicle Concentration in Circulation
por: Alberro, Ainhoa, et al.
Publicado: (2016)

High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML
por: Aldaz, Paula, et al.
Publicado: (2022)

Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with CAPN3 Mutations
por: Lasa-Elgarresta, Jaione, et al.
Publicado: (2019)

NaviSE: superenhancer navigator integrating epigenomics signal algebra
por: Ascensión, Alex M., et al.
Publicado: (2017)

Quantifying Cancer Absolute Risk and Cancer Mortality in the Presence of Competing Events after a Myotonic Dystrophy Diagnosis
por: Gadalla, Shahinaz M., et al.
Publicado: (2013)

Primary cilium and glioblastoma
por: Álvarez-Satta, María, et al.
Publicado: (2018)

Impact of Chaperone-Mediated Autophagy in Brain Aging: Neurodegenerative Diseases and Glioblastoma
por: Auzmendi-Iriarte, Jaione, et al.
Publicado: (2021)

Expression of cellular senescence and neural stem cell markers in a case of advanced retinal fibrosis
por: Moreno‐Valladares, Manuel, et al.
Publicado: (2019)

Altered expression of proteins involved in metabolism in LGMDR1 muscle is lost in cell culture conditions
por: Rico, Anabel, et al.
Publicado: (2023)

Allosteric Modulation of GSK-3β as a New Therapeutic Approach in Limb Girdle Muscular Dystrophy R1 Calpain 3-Related
por: Rico, Anabel, et al.
Publicado: (2021)

In vitro P38MAPK inhibition in aged astrocytes decreases reactive astrocytes, inflammation and increases nutritive capacity after oxygen-glucose deprivation
por: Revuelta, Miren, et al.
Publicado: (2021)

Stem Cells in Translational Cancer Research
por: Okamoto, Oswaldo Keith, et al.
Publicado: (2015)

Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment
por: Iturrioz-Rodríguez, Nerea, et al.
Publicado: (2023)

Benign tumors in myotonic dystrophy type I target disease‐related cancer sites
por: Alsaggaf, Rotana, et al.
Publicado: (2019)

SOX2 haploinsufficiency promotes impaired vision at advanced age
por: Moreno-Cugnon, Leire, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u6ue000mqjna0o2slfa5l3l3m8